Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
BETA DRUGS LTD.
Beta Drugs Ltd.
NSE: BETA | BSE: 531481
Download real time
1698.60
-21.10
(
-1.23
%)
48.50% Gain from 52W Low
1,995
NSE Volume
NSE
30 Jul, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Beta Drugs Ltd. - BETA, 531481 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Beta Drugs Ltd.
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Bonus history for Beta Drugs Ltd.
Beta Drugs Ltd. has given 1 bonus since March 26, 2025. The last Bonus that Beta Drugs Ltd. anoununced was in the ratio 1:20 with ex-date of March 26, 2025.
Ex-Date
Bonus Ratio
Record Date
26 Mar 2025
1:20
26 Mar 2025
See all forthcoming Bonus and split
Beta Drugs Ltd. Split history
Beta Drugs Ltd. has not split the face value of the share since Jan 1, 2000.
See all forthcoming Bonus and Splits
Beta Drugs Ltd. Dividend history
Beta Drugs Ltd. has not given any dividends since Jan 1, 2000.
See all forthcoming dividends
Board Meetings - Beta Drugs Ltd.
The latest board meeting for Beta Drugs Ltd. took place on 15 May 2025, for the purpose of Audited Results
Ex-Date
Purpose
Notes
15 May 2025
Audited Results
-
27 Mar 2025
Others
To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue.
05 Feb 2025
Issue of Bonus & Others
To consider other business matters.
06 Nov 2024
Quarterly Results
-
19 Oct 2024
To consider Fund Raising
-
14 May 2024
Audited Results
-
07 Nov 2023
Quarterly Results & Others
To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE.
08 May 2023
Audited Results
-
27 Oct 2022
Quarterly Results
-
27 Apr 2022
Audited Results
-
See all Board Meetings for Beta Drugs Ltd.
Beta Drugs Ltd. Rights history
Beta Drugs Ltd. has not issued
any
rights since Jan 1, 2000.
See all Rights History for Beta Drugs Ltd.